Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer.
Amber Marie D'SouzaManu GnanamonyMaria ThomasPeter HanleyDipti KanabarPedro de AlarconAaron MuthNikolai TimchenkoPublished in: Cancers (2022)
Small-molecule inhibitors for Gankyrin are a promising therapeutic strategy, especially in combination with doxorubicin.